国产午夜福利片1000无码丨人妻国产成人久久av免费高清丨午夜做受视频试看6次丨日韩av不卡一区在线免费观看丨在线观看精品三级欧美

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號 規(guī)格
Recombinant Escherichia coli DNA mismatch repair protein MutS (mutS), partial CSB-YP540103ENX
CSB-EP540103ENX
CSB-BP540103ENX
CSB-MP540103ENX
CSB-EP540103ENX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli Fumarate reductase subunit C (frdC), partial CSB-YP540104ENX1
CSB-EP540104ENX1
CSB-BP540104ENX1
CSB-MP540104ENX1
CSB-EP540104ENX1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli Adenylosuccinate synthetase (purA) CSB-YP540105ENX
CSB-EP540105ENX
CSB-BP540105ENX
CSB-MP540105ENX
CSB-EP540105ENX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli L-ribulose-5-phosphate 3-epimerase UlaE (ulaE) CSB-YP540106ENX
CSB-EP540106ENX
CSB-BP540106ENX
CSB-MP540106ENX
CSB-EP540106ENX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli Flagellar protein FliT (fliT) CSB-YP540107ENX
CSB-EP540107ENX
CSB-BP540107ENX
CSB-MP540107ENX
CSB-EP540107ENX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli Lysophospholipid transporter lplT (lplT), partial CSB-YP540108ENX
CSB-EP540108ENX
CSB-BP540108ENX
CSB-MP540108ENX
CSB-EP540108ENX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli Fructose-1,6-bisphosphatase class 1 (fbp) CSB-YP540109ENX
CSB-EP540109ENX
CSB-BP540109ENX
CSB-MP540109ENX
CSB-EP540109ENX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Methylobacterium radiotolerans Sulfite reductase [NADPH] hemoprotein beta-component (cysI), partial CSB-YP540110MTD
CSB-EP540110MTD
CSB-BP540110MTD
CSB-MP540110MTD
CSB-EP540110MTD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Methylobacterium radiotolerans DNA-directed RNA polymerase subunit omega (rpoZ) CSB-YP540111MTD
CSB-EP540111MTD
CSB-BP540111MTD
CSB-MP540111MTD
CSB-EP540111MTD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Methylobacterium radiotolerans UDP-3-O-acylglucosamine N-acyltransferase (lpxD) CSB-YP540112MTD
CSB-EP540112MTD
CSB-BP540112MTD
CSB-MP540112MTD
CSB-EP540112MTD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Methylobacterium radiotolerans Aspartyl/glutamyl-tRNA (Asn/Gln) amidotransferase subunit C CSB-YP540113MTD
CSB-EP540113MTD
CSB-BP540113MTD
CSB-MP540113MTD
CSB-EP540113MTD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Methylobacterium radiotolerans Glutamate--tRNA ligase 1 (gltX1) CSB-YP540114MTD
CSB-EP540114MTD
CSB-BP540114MTD
CSB-MP540114MTD
CSB-EP540114MTD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Methylobacterium radiotolerans NADH-quinone oxidoreductase subunit I (nuoI) CSB-YP540115MTD
CSB-EP540115MTD
CSB-BP540115MTD
CSB-MP540115MTD
CSB-EP540115MTD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Methylobacterium radiotolerans UPF0262 protein Mrad2831_3513 (Mrad2831_3513) CSB-YP540116MTD
CSB-EP540116MTD
CSB-BP540116MTD
CSB-MP540116MTD
CSB-EP540116MTD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Methylobacterium radiotolerans Biotin synthase (bioB) CSB-YP540117MTD
CSB-EP540117MTD
CSB-BP540117MTD
CSB-MP540117MTD
CSB-EP540117MTD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Methylobacterium radiotolerans 10 kDa chaperonin (groS) CSB-YP540118MTD
CSB-EP540118MTD
CSB-BP540118MTD
CSB-MP540118MTD
CSB-EP540118MTD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Methylobacterium radiotolerans 50S ribosomal protein L24 (rplX) CSB-YP540119MTD
CSB-EP540119MTD
CSB-BP540119MTD
CSB-MP540119MTD
CSB-EP540119MTD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Methylobacterium radiotolerans 30S ribosomal protein S19 (rpsS) CSB-YP540120MTD
CSB-EP540120MTD
CSB-BP540120MTD
CSB-MP540120MTD
CSB-EP540120MTD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Methylobacterium radiotolerans D-alanine--D-alanine ligase (ddl) CSB-YP540121MTD
CSB-EP540121MTD
CSB-BP540121MTD
CSB-MP540121MTD
CSB-EP540121MTD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Methylobacterium radiotolerans Flavoprotein wrbA (wrbA) CSB-YP540122MTD
CSB-EP540122MTD
CSB-BP540122MTD
CSB-MP540122MTD
CSB-EP540122MTD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長度(全長或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時,你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個有用的技巧來選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://www.jhhuazhong.com/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們在線留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>